MELBOURNE (Reuters) - Australian healthcare group Symbion Health Ltd and suitor Healthscope Ltd plan fresh talks on a tie-up after shareholders rejected Healthscope's A$2.9 billion ($2.4 billion) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results